Skip to main content
Erschienen in: Pediatric Nephrology 5/2009

01.05.2009 | Original Article

Genotype–phenotype correlation in children with autosomal dominant polycystic kidney disease

verfasst von: Filip Fencl, Jan Janda, Květa Bláhová, Zdeněk Hříbal, Jitka Štekrová, Alena Puchmajerová, Tomáš Seeman

Erschienen in: Pediatric Nephrology | Ausgabe 5/2009

Einloggen, um Zugang zu erhalten

Abstract

Adults with autosomal dominant polycystic kidney disease (ADPKD) and PKD1 mutations have a more severe disease than do patients with PKD2 mutations. The aim of this study was to compare phenotypes between children with mutations in the PKD1/PKD2 genes. Fifty PKD1 children and ten PKD2 children were investigated. Their mean age was similar (8.6 ± 5.4 years and 8.9 ± 5.6 years). Renal ultrasound was performed, and office blood pressure (BP), ambulatory BP, creatinine clearance and proteinuria were measured. The PKD1 children had, in comparison with those with PKD2, significantly greater total of renal cysts (13.3 ± 12.5 vs 3.0 ± 2.1, P = 0.004), larger kidneys [right/left kidney length 0.89 ± 1.22 standard deviation score (SDS) vs 0.17 ± 1.03 SDS, P = 0.045, and 1.19 ± 1.42 SDS vs 0.12 ± 1.09 SDS, P = 0.014, successively] and higher ambulatory day-time and night-time systolic BP (day-time/night-time BP index 0.93 ± 0.10 vs 0.86 ± 0.05, P = 0.021 and 0.94 ± 0.07 vs 0.89 ± 0.04, P = 0.037, successively). There were no significant differences in office BP, creatinine clearance or proteinuria. Prenatal renal cysts (14%), hypertension defined by ambulatory BP (27%) and enlarged kidneys (32%) were observed only in the PKD1 children. This is the first study on genotype–phenotype correlation in children with ADPKD. PKD1 children have more and larger renal cysts, larger kidneys and higher ambulatory BP than do PKD2 children. Renal cysts and enlarged kidneys detected prenatally are highly specific for children with PKD1.
Literatur
1.
Zurück zum Zitat Gabow PA, Johnson AM, Kaehny WD, Kimberling WJ, Lezotte DC, Duley IT, Jones RH (1992) Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease. Kidney Int 41:1311–1319CrossRef Gabow PA, Johnson AM, Kaehny WD, Kimberling WJ, Lezotte DC, Duley IT, Jones RH (1992) Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease. Kidney Int 41:1311–1319CrossRef
2.
Zurück zum Zitat Gabow PA (1993) Autosomal dominant polycystic kidney disease. N Engl J Med 329:332–342CrossRef Gabow PA (1993) Autosomal dominant polycystic kidney disease. N Engl J Med 329:332–342CrossRef
3.
Zurück zum Zitat Gabow PA (1990) Autosomal dominant polycystic kidney disease: more than a renal disease. Am J Kidney Dis 16:403–413CrossRef Gabow PA (1990) Autosomal dominant polycystic kidney disease: more than a renal disease. Am J Kidney Dis 16:403–413CrossRef
4.
Zurück zum Zitat Peters DJM, Sandkuijl LA (1992) Genetic heterogeneity of polycystic kidney disease in Europe. Contrib Nephrol 97:128–139CrossRef Peters DJM, Sandkuijl LA (1992) Genetic heterogeneity of polycystic kidney disease in Europe. Contrib Nephrol 97:128–139CrossRef
5.
Zurück zum Zitat Daoust MC, Reynolds DM, Bichet DG, Somlo S (1995) Evidence for a third genetic locus for autosomal dominant polycystic kidney disease. Genomics 25:733–736CrossRef Daoust MC, Reynolds DM, Bichet DG, Somlo S (1995) Evidence for a third genetic locus for autosomal dominant polycystic kidney disease. Genomics 25:733–736CrossRef
6.
Zurück zum Zitat Turco AE, Clementi M, Rosetti S, Tneconi R, Franco Pignatti P (1996) An Italian family with autosomal dominant polycystic kidney disease unlinked to either the PKD1 or PKD2 gene. Am J Kidney Dis 28:759–761CrossRef Turco AE, Clementi M, Rosetti S, Tneconi R, Franco Pignatti P (1996) An Italian family with autosomal dominant polycystic kidney disease unlinked to either the PKD1 or PKD2 gene. Am J Kidney Dis 28:759–761CrossRef
7.
Zurück zum Zitat Ariza M, Alvarez V, Marín R, Aguado S, López-Larrea C, Alvarez J, Menéndez MJ, Coto E (1997) A family with a milder form of adult dominant polycystic kidney disease not linked to the PKD1 (16p) or PKD2 (4q) genes. J Med Genet 34:587–589CrossRef Ariza M, Alvarez V, Marín R, Aguado S, López-Larrea C, Alvarez J, Menéndez MJ, Coto E (1997) A family with a milder form of adult dominant polycystic kidney disease not linked to the PKD1 (16p) or PKD2 (4q) genes. J Med Genet 34:587–589CrossRef
8.
Zurück zum Zitat Ravine D, Walker RG, Gibson RN, Forrest SM, Richards RI, Friend K, Sheffield LJ, Kincaid-Smith P, Danks DM (1992) Phenotype and genotype heterogenity in autosomal dominant polycystic kidney disease. Lancet 340:1330–1333CrossRef Ravine D, Walker RG, Gibson RN, Forrest SM, Richards RI, Friend K, Sheffield LJ, Kincaid-Smith P, Danks DM (1992) Phenotype and genotype heterogenity in autosomal dominant polycystic kidney disease. Lancet 340:1330–1333CrossRef
9.
Zurück zum Zitat Torra R, Badenas C, Darnell A, Nicolau C, Volpini V, Revert L, Estivill X (1996) Linkage, clinical features, and prognosis of autosomal dominant polycystic disease type 1 and 2. J Am Soc Nephrol 7:2142–2151PubMed Torra R, Badenas C, Darnell A, Nicolau C, Volpini V, Revert L, Estivill X (1996) Linkage, clinical features, and prognosis of autosomal dominant polycystic disease type 1 and 2. J Am Soc Nephrol 7:2142–2151PubMed
10.
Zurück zum Zitat Hateboer N, v Dijk MA, Bogdanova N, Coto E, Saggar-Malik AK, San Millan JL, Torra R, Breuning M, Ravine D, European PKD1–PKD2 Study Group (1999) Comparison of phenotypes of polycystic kidney disease types 1 and 2. Lancet 353:103–107CrossRef Hateboer N, v Dijk MA, Bogdanova N, Coto E, Saggar-Malik AK, San Millan JL, Torra R, Breuning M, Ravine D, European PKD1–PKD2 Study Group (1999) Comparison of phenotypes of polycystic kidney disease types 1 and 2. Lancet 353:103–107CrossRef
11.
Zurück zum Zitat Harris PC, Bae KT, Rossetti S, Torres VE, Grantham JJ, Chapman AB, Guay-Woodford LM, King BF, Wetzel LH, Baumgarten DA, Kenney PJ, Consugar M, Klahr S, Bennett WM, Meyers CM, Zhang QJ, Thompson PA, Zhu F, Miller JP (2006) Cyst number but not the rate of cystic growth is associated with the mutated gene in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 17:3013–3019CrossRef Harris PC, Bae KT, Rossetti S, Torres VE, Grantham JJ, Chapman AB, Guay-Woodford LM, King BF, Wetzel LH, Baumgarten DA, Kenney PJ, Consugar M, Klahr S, Bennett WM, Meyers CM, Zhang QJ, Thompson PA, Zhu F, Miller JP (2006) Cyst number but not the rate of cystic growth is associated with the mutated gene in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 17:3013–3019CrossRef
12.
Zurück zum Zitat Kaplan BS, Rabin I, Nogrady MB, Drummond KN (1977) Autosomal dominant polycystic renal disease in children. J Pediatr 90:782–783CrossRef Kaplan BS, Rabin I, Nogrady MB, Drummond KN (1977) Autosomal dominant polycystic renal disease in children. J Pediatr 90:782–783CrossRef
13.
Zurück zum Zitat Kääriäinen H, Koskimies O, Norio R (1988) Dominant and recessive polycystic kidney disease in children: evaluation of clinical features and laboratory data. Pediatr Nephrol 2:296–302CrossRef Kääriäinen H, Koskimies O, Norio R (1988) Dominant and recessive polycystic kidney disease in children: evaluation of clinical features and laboratory data. Pediatr Nephrol 2:296–302CrossRef
14.
Zurück zum Zitat Gagnadoux MF, Habib R, Levy M, Brunelle F, Broyer M (1989) Cystic renal diseases in children. Adv Nephrol 18:33–58 Gagnadoux MF, Habib R, Levy M, Brunelle F, Broyer M (1989) Cystic renal diseases in children. Adv Nephrol 18:33–58
15.
Zurück zum Zitat Zerres K, Rudnik-Schöneborn S, Deget F (1993) Childhood onset autosomal dominant polycystic kidney disease in sibs: clinical picture and recurrence risk. German Working Group on Paediatric Nephrology (Arbeitsgemeinschaft für Pädiatrische Nephrologie). J Med Genet 30:583–588CrossRef Zerres K, Rudnik-Schöneborn S, Deget F (1993) Childhood onset autosomal dominant polycystic kidney disease in sibs: clinical picture and recurrence risk. German Working Group on Paediatric Nephrology (Arbeitsgemeinschaft für Pädiatrische Nephrologie). J Med Genet 30:583–588CrossRef
16.
Zurück zum Zitat Fick GM, Johnson AM, Strain JD, Kimberling WJ, Kumar S, Manco-Johnson ML, Duley IT, Gabow PA (1993) Characteristics of very early onset autosomal dominant polycystic kidney disease. J Am Soc Nephrol 3:1863–1870PubMed Fick GM, Johnson AM, Strain JD, Kimberling WJ, Kumar S, Manco-Johnson ML, Duley IT, Gabow PA (1993) Characteristics of very early onset autosomal dominant polycystic kidney disease. J Am Soc Nephrol 3:1863–1870PubMed
17.
Zurück zum Zitat MacDermot KD, Saggar-Malik AK, Economides DL, Jeffery S (1998) Prenatal diagnosis of autosomal dominant polycystic kidney disease (PKD1) presenting in utero and prognosis for very early onset disease. J Med Genet 35:13–16CrossRef MacDermot KD, Saggar-Malik AK, Economides DL, Jeffery S (1998) Prenatal diagnosis of autosomal dominant polycystic kidney disease (PKD1) presenting in utero and prognosis for very early onset disease. J Med Genet 35:13–16CrossRef
18.
Zurück zum Zitat Seeman T, Sikut M, Konrad M, Vondrichova H, Janda J, Scharer K (1997) Blood pressure and renal function in autosomal dominant polycystic kidney disease. Pediatr Nephrol 11:592–596CrossRef Seeman T, Sikut M, Konrad M, Vondrichova H, Janda J, Scharer K (1997) Blood pressure and renal function in autosomal dominant polycystic kidney disease. Pediatr Nephrol 11:592–596CrossRef
19.
Zurück zum Zitat Boyer O, Gagnadoux MF, Guest G, Biebuyck N, Charbit M, Salomon R, Niaudet P (2007) Prognosis of autosomal dominant polycystic kidney disease diagnosed in utero or at birth. Pediatr Nephrol 22:380–388CrossRef Boyer O, Gagnadoux MF, Guest G, Biebuyck N, Charbit M, Salomon R, Niaudet P (2007) Prognosis of autosomal dominant polycystic kidney disease diagnosed in utero or at birth. Pediatr Nephrol 22:380–388CrossRef
20.
Zurück zum Zitat Hayashi T, Mochizuki T, Reynolds DM, Wu G, Cai Y, Somlo S (1997) Characterization of the exon structure of the polycystic kidney disease 2 gene (PKD2). Genomics 44:131–136CrossRef Hayashi T, Mochizuki T, Reynolds DM, Wu G, Cai Y, Somlo S (1997) Characterization of the exon structure of the polycystic kidney disease 2 gene (PKD2). Genomics 44:131–136CrossRef
21.
Zurück zum Zitat Reiterová J, Štekrová J, Peters DJ, Kapras J, Kohoutová M, Merta M, Zidovská J (2002) Four novel mutations of the PKD2 gene in Czech families with autosomal dominant polycystic kidney disease. Hum Mutat 19:573CrossRef Reiterová J, Štekrová J, Peters DJ, Kapras J, Kohoutová M, Merta M, Zidovská J (2002) Four novel mutations of the PKD2 gene in Czech families with autosomal dominant polycystic kidney disease. Hum Mutat 19:573CrossRef
22.
Zurück zum Zitat Štekrová J, Reiterová J, Merta M, Damborsky J, Zidovská J, Kebrdlová V, Kohoutová M (2004) PKD2 mutations in a Czech population with autosomal dominant polycystic kidney disease. Nephrol Dial Transplant 19:1116–1122CrossRef Štekrová J, Reiterová J, Merta M, Damborsky J, Zidovská J, Kebrdlová V, Kohoutová M (2004) PKD2 mutations in a Czech population with autosomal dominant polycystic kidney disease. Nephrol Dial Transplant 19:1116–1122CrossRef
23.
Zurück zum Zitat Veldhuisen B, Saris JJ, de Haij S, Hayashi T, Reynolds DM, Mochizuki T, Elles R, Fossdal R, Bogdanova N, van Dijk MA, Coto E, Ravine D, Nørby S, Verellen-Dumoulin C, Breuning MH, Somlo S, Peters DJ (1997) A spectrum of mutations in the second gene for autosomal dominant polycystic kidney disease (PKD2). Am J Hum Genet 61:547–555CrossRef Veldhuisen B, Saris JJ, de Haij S, Hayashi T, Reynolds DM, Mochizuki T, Elles R, Fossdal R, Bogdanova N, van Dijk MA, Coto E, Ravine D, Nørby S, Verellen-Dumoulin C, Breuning MH, Somlo S, Peters DJ (1997) A spectrum of mutations in the second gene for autosomal dominant polycystic kidney disease (PKD2). Am J Hum Genet 61:547–555CrossRef
24.
Zurück zum Zitat Dinkel E, Ertel M, Dittrich M, Peters H, Berres M, Schulte-Wissermann H (1985) Kidney size in childhood sonographical growth charts for kidney length and volume. Pediatr Radiol 15:38–43CrossRef Dinkel E, Ertel M, Dittrich M, Peters H, Berres M, Schulte-Wissermann H (1985) Kidney size in childhood sonographical growth charts for kidney length and volume. Pediatr Radiol 15:38–43CrossRef
25.
Zurück zum Zitat Schwartz GJ, Brion LP, Spitzer A (1987) The use of plasma creatinine concentration to estimate glomerular filtration rate in infancy, childhood and adolescence. Pediatr Clin North Am 34:571–590CrossRef Schwartz GJ, Brion LP, Spitzer A (1987) The use of plasma creatinine concentration to estimate glomerular filtration rate in infancy, childhood and adolescence. Pediatr Clin North Am 34:571–590CrossRef
26.
Zurück zum Zitat Hogg RJ, Furth S, Lemley KV, Portman R, Schwartz GJ, Coresh J, Balk E, Lau J, Levin A, Kausz AT, Eknoyan G, Levey AS (2003) National Kidney Foundation’s Kidney Disease Outcomes Quality Initiative Clinical Practice Guidelines for Chronic Kidney Disease in Children and Adolescents: Evaluation, Classification, and Stratification. Pediatrics 111:1416–1421CrossRef Hogg RJ, Furth S, Lemley KV, Portman R, Schwartz GJ, Coresh J, Balk E, Lau J, Levin A, Kausz AT, Eknoyan G, Levey AS (2003) National Kidney Foundation’s Kidney Disease Outcomes Quality Initiative Clinical Practice Guidelines for Chronic Kidney Disease in Children and Adolescents: Evaluation, Classification, and Stratification. Pediatrics 111:1416–1421CrossRef
27.
Zurück zum Zitat National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents (2004) The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 114 [2 Suppl 4th Report]:555–576CrossRef National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents (2004) The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 114 [2 Suppl 4th Report]:555–576CrossRef
28.
Zurück zum Zitat Soergel M, Kirschstein M, Busch C, Danne T, Gellermann J, Holl R, Krull F, Reichert H, Reusz GS, Rascher W (1997) Oscillometric twenty-four hour ambulatory blood pressure values in healthy children and adolescents: a multicenter trial including 1141 subjects. J Pediatr 130:178–184CrossRef Soergel M, Kirschstein M, Busch C, Danne T, Gellermann J, Holl R, Krull F, Reichert H, Reusz GS, Rascher W (1997) Oscillometric twenty-four hour ambulatory blood pressure values in healthy children and adolescents: a multicenter trial including 1141 subjects. J Pediatr 130:178–184CrossRef
29.
Zurück zum Zitat Rizk D, Chapman A (2008) Treatment of autosomal dominant polycystic kidney disease (ADPKD): the new horizon for children with ADPKD. Pediatr Nephrol 23:1029–1036CrossRef Rizk D, Chapman A (2008) Treatment of autosomal dominant polycystic kidney disease (ADPKD): the new horizon for children with ADPKD. Pediatr Nephrol 23:1029–1036CrossRef
30.
Zurück zum Zitat Wingen AM (1997) Chronic kidney failure—etiology and sequelae (in German). Kinderkrankenschwester 16:132–134PubMed Wingen AM (1997) Chronic kidney failure—etiology and sequelae (in German). Kinderkrankenschwester 16:132–134PubMed
31.
Zurück zum Zitat Geberth S, Stier E, Zeier M, Mayer G, Rambousek M, Ritz E (1995) More adverse renal prognosis of autosomal dominant polycystic kidney disease in families with primary hypertension. J Am Soc Nephrol 6:1643–1648PubMed Geberth S, Stier E, Zeier M, Mayer G, Rambousek M, Ritz E (1995) More adverse renal prognosis of autosomal dominant polycystic kidney disease in families with primary hypertension. J Am Soc Nephrol 6:1643–1648PubMed
32.
Zurück zum Zitat Choukroun G, Itakura Y, Albouze G, Christophe JL, Man NK, Grünfeld JP, Jungers P (1996) Factors influencing progression of renal failure in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 6:1634–1642 Choukroun G, Itakura Y, Albouze G, Christophe JL, Man NK, Grünfeld JP, Jungers P (1996) Factors influencing progression of renal failure in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 6:1634–1642
33.
Zurück zum Zitat Shamshirsaz AA, Reza Bekheirnia M, Kamgar M, Johnson AM, McFann K, Cadnapaphornchai M, Nobakhthaghighi N, Schrier RW (2005) Autosomal-dominant polycystic kidney disease in infancy and childhood: progression and outcome. Kidney Int 68:2218–2224CrossRef Shamshirsaz AA, Reza Bekheirnia M, Kamgar M, Johnson AM, McFann K, Cadnapaphornchai M, Nobakhthaghighi N, Schrier RW (2005) Autosomal-dominant polycystic kidney disease in infancy and childhood: progression and outcome. Kidney Int 68:2218–2224CrossRef
Metadaten
Titel
Genotype–phenotype correlation in children with autosomal dominant polycystic kidney disease
verfasst von
Filip Fencl
Jan Janda
Květa Bláhová
Zdeněk Hříbal
Jitka Štekrová
Alena Puchmajerová
Tomáš Seeman
Publikationsdatum
01.05.2009
Verlag
Springer Berlin Heidelberg
Erschienen in
Pediatric Nephrology / Ausgabe 5/2009
Print ISSN: 0931-041X
Elektronische ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-008-1090-9

Weitere Artikel der Ausgabe 5/2009

Pediatric Nephrology 5/2009 Zur Ausgabe

Kinder mit anhaltender Sinusitis profitieren häufig von Antibiotika

30.04.2024 Rhinitis und Sinusitis Nachrichten

Persistieren Sinusitisbeschwerden bei Kindern länger als zehn Tage, ist eine Antibiotikatherapie häufig gut wirksam: Ein Therapieversagen ist damit zu über 40% seltener zu beobachten als unter Placebo.

Neuer Typ-1-Diabetes bei Kindern am Wochenende eher übersehen

23.04.2024 Typ-1-Diabetes Nachrichten

Wenn Kinder an Werktagen zum Arzt gehen, werden neu auftretender Typ-1-Diabetes und diabetische Ketoazidosen häufiger erkannt als bei Arztbesuchen an Wochenenden oder Feiertagen.

Neue Studienergebnisse zur Myopiekontrolle mit Atropin

22.04.2024 Fehlsichtigkeit Nachrichten

Augentropfen mit niedrig dosiertem Atropin können helfen, das Fortschreiten einer Kurzsichtigkeit bei Kindern zumindest zu verlangsamen, wie die Ergebnisse einer aktuellen Studie mit verschiedenen Dosierungen zeigen.

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

18.04.2024 Spinale Muskelatrophien Nachrichten

Seit 2021 ist die Untersuchung auf spinale Muskelatrophie Teil des Neugeborenen-Screenings in Deutschland. Eine Studie liefert weitere Evidenz für den Nutzen der Maßnahme.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.